SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,459.53 308.49
( 0.42%)

Global Indices

Nasdaq

52,356.08 -140.02
(-0.27%)

Dow Jones

7,741.04 -23.94
(-0.31%)

Hang Seng

63,176.05 -1,483.42
(-2.29%)

Nikkei 225

10,722.51 0.44
(0.00%)

Forex

USD-INR

95.16 0.08
(0.08%)

EUR-INR

105.95 -0.06
(-0.06%)

GBP-INR

126.57 -0.09
(-0.07%)

JPY-INR

0.60 0.00
(-0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

199.4246723

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

43.29

12866.75

EPS(TTM)

Face Value()

Div & Yield %

28.41

0.61

Back

infosys ltd

Ram Ratna Wires consolidated net profit rises 127.75% in the June 2026 quarter

Aug 01,2026

Net profit of Ram Ratna Wires rose 127.75% to Rs 35.21 crore in the quarter ended June 2026 as against Rs 15.46 crore during the previous quarter ended June 2025. Sales rose 88.63% to Rs 1853.28 crore in the quarter ended June 2026 as against Rs 982.47 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1853.28	982.47	89
OPM %	4.76	4.36	-
PBDT	58.86	30.65	92
PBT	46.09	22.40	106
NP	35.21	15.46	128

74,459.53 308.49 ( 0.42%)

52,356.08 -140.02 (-0.27%)

7,741.04 -23.94 (-0.31%)

63,176.05 -1,483.42 (-2.29%)

10,722.51 0.44 (0.00%)

95.16 0.08 (0.08%)

105.95 -0.06 (-0.06%)

126.57 -0.09 (-0.07%)

0.60 0.00 (-0.01%)